首页> 外文期刊>Scientific reports. >Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study
【24h】

Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study

机译:结直肠癌的发展预测酒精性肝病患者随后发生肝细胞癌的风险增加:病例对照和队列研究

获取原文
获取外文期刊封面目录资料

摘要

Alcohol increases the risk of both hepatocellular carcinoma (HCC) and colorectal neoplasia. In this hospital-based case-control and retrospective cohort study, we sought to determine whether development of colorectal neoplasia increases the risk of HCC in patients with alcoholic liver disease (ALD). In the phase I case-control analysis, the association between history of colorectal cancer (CRC) and HCC development was assessed in patients with ALD by logistic regression modeling (n?=?1,659). In the phase II retrospective cohort analysis, the relative risk of HCC development was compared in ALD patients with respect to the history of CRC by a Cox model (n?=?1,184). The history of CRC was significantly associated with HCC in the case-control analysis (adjusted odds ratio, 1.82; 95% CI, 1.06-3.15; P??0.05). ALD patients with CRC had higher risk of developing HCC compared to those without CRC (adjusted hazards ratio [HR], 5.48; 95% CI, 1.63-18.36; P?=?0.006) in the cohort analysis. Presence of CRC, liver cirrhosis, elevated baseline alpha-fetoprotein level, and low platelet counts were independent predictors of HCC development in ALD patients. Patients with history of CRC had an increased risk of HCC in both cirrhotic (HR, 3.76; 95% CI, 1.05-13.34, P?=?0.041) and non-cirrhotic (HR, 23.46; 95% CI, 2.81-195.83, P?=?0.004) ALD patients. In conclusion, ALD patients with CRC are at increased risk of developing HCC.
机译:酒精会增加患肝细胞癌(HCC)和结直肠癌的风险。在这项基于医院的病例对照和回顾性队列研究中,我们试图确定结直肠肿瘤的发展是否会增加酒精性肝病(ALD)患者的HCC风险。在I期病例对照分析中,通过logistic回归模型评估了ALD患者大肠癌史(CRC)与HCC发生之间的相关性(n≥1,659)。在II期回顾性队列分析中,通过Cox模型比较了ALD患者相对于CRC病史的HCC发生的相对风险(n?=?1,184)。在病例对照分析中,CRC的病史与HCC显着相关(校正比值比为1.82; 95%CI为1.06-3.15; P <0.05)。在队列分析中,与没有CRC的ALD患者相比,没有CRC的ALD患者发生HCC的风险更高(调整后的危险比[HR]为5.48; 95%CI为1.63-18.36; P <= 0.006)。 CRC,肝硬化,基线甲胎蛋白水平升高和血小板计数低是ALD患者肝癌发展的独立预测因子。有CRC病史的患者在肝硬化(HR,3.76; 95%CI,1.05-13.34,P?=?0.041)和非肝硬化(HR,23.46; 95%CI,2.81-195.83, P≥0.004)ALD患者。总之,患有CRC的ALD患者患肝癌的风险增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号